Agency Information Collection Activities: Proposed Collection; Comment Request
Notice.
Citation: "88 FR 16635"
Document Number: "Document Identifiers CMS-P-0015A"
Page Number: "16635"
"Notices"
Agency: "
SUMMARY: The
DATES: Comments must be received by
ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to http://www.regulations.gov. Follow the instructions for "Comment or Submission" or "More Search Options" to find the information collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following address: CMS,
To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection's supporting statement and associated materials (see ADDRESSES).
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain approval from the
Information Collection
1. Type of Information Collection Request: Revision of currently approved collection; Title of Information Collection:
The MCBS continues to provide unique insight into the Medicare program and helps CMS and our external stakeholders better understand and evaluate the impact of existing programs and significant new policy initiatives. In the past, MCBS data have been used to assess potential changes to the Medicare program. For example, the MCBS was instrumental in supporting the development and implementation of the Medicare prescription drug benefit by providing a means to evaluate prescription drug costs and out-of-pocket burden for these drugs to Medicare beneficiaries. Beginning in 2024, this proposed revision to the clearance will add a few new measures to existing questionnaire sections and will remove COVID-19-related content that is no longer relevant for administration. Updated respondent materials are also included in this request. The revisions will result in a net decrease in respondent burden as compared to the current clearance due to the removal of COVID-19 items. Form Number: CMS-P-0015A (OMB control number: 0938-0568); Frequency: Occasionally; Affected Public Sector: Business or other for-profits and Not-for-profit institutions; Number of Respondents: 13,568; Total Annual Responses: 35,015; Total Annual Hours: 34,380. (For policy questions regarding this collection contact
Dated:
Director, Paperwork Reduction Staff,
[FR Doc. 2023-05628 Filed 3-17-23;
BILLING CODE 4120-01-P


How to shop for new insurance if you lose Medicaid coverage
China Stock Market Expected To Open In The Red [Real-Time Trader]
Advisor News
- House panel advances CLEAR Forms Act backed by IRI
- Modifying life insurance based on evolving needs
- Gen X faces ‘pension envy’ as they head into retirement
- Your client wants to cash out an annuity. Here’s what to consider
- How student loan debt impacts 401(k) balances
More Advisor NewsAnnuity News
- A-Cap strikes back with lawsuit accusing SC regulators of sloppy process, leaking secrets
- AM Best to Discuss Its Views on Private Credit Surge and Risks at 2026 NAIC/NIPR Insurance Summit
- OID recovers $260M in life insurance benefits
- NUNN BILLS TO COMBAT PAYMENT SCAMS, CUT FINANCIAL RED TAPE PASS FINANCIAL SERVICES COMMITTEE
- SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
More Annuity NewsHealth/Employee Benefits News
Life Insurance News